The last NephJC of the year brought us a cool discussion on if cooling dialysate could help mitigate the effects of intradialytic hypotension. Get caught up with the chat in the latest edition of #TenTweetNephJC.
This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
The summer book club started in 2015, with one of the best books we have done in book club, Atul Gawande's Being Mortal. I think it should be required reading for all physicians. So now, in 2025, it is the NephJC Summer Book’s tenth anniversary (which represents our eleventh book). The history has been rich:
The last NephJC of the year brought us a cool discussion on if cooling dialysate could help mitigate the effects of intradialytic hypotension. Get caught up with the chat in the latest edition of #TenTweetNephJC.
Last #TenTweetNephJC thread of 2022
— Nephrology Journal Club (@NephJC) December 28, 2022
Intradialytic hypotension (IDH) is deeply unpleasant but very common. We hope cooling dialysate to cause vasoconstriction prevents IDH, helping prevent myocardial stunning.
So does cooling dialysate improve cardiovascular outcomes? pic.twitter.com/mmNoIxlDxk